−28.01MXN
−10.24 BMXN
151.47 BMXN
356.59 M
About BAUSCH HEALTH COMPANIES INC
Sector
CEO
Thomas J. Appio
Headquarters
Laval
Website
Employees (FY)
20.27 K
Founded
1994
ISIN
CA0717341071
FIGI
BBG0077HC5W9
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BHC/N is 174.30 MXN — it has increased by 19.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange BAUSCH HEALTH COMPANIES INC stocks are traded under the ticker BHC/N.
BAUSCH HEALTH COMPANIES INC is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
BHC/N stock is 16.32% volatile and has beta coefficient of 1.45. Check out the list of the most volatile stocks — is BAUSCH HEALTH COMPANIES INC there?
One year price forecast for BAUSCH HEALTH COMPANIES INC has a max estimate of 272.92 MXN and a min estimate of 117.99 MXN.
BHC/N earnings for the last quarter are 19.00 MXN per share, whereas the estimation was 16.15 MXN resulting in a 17.62% surprise. The estimated earnings for the next quarter are 17.64 MXN per share. See more details about BAUSCH HEALTH COMPANIES INC earnings.
BAUSCH HEALTH COMPANIES INC revenue for the last quarter amounts to 39.60 B MXN despite the estimated figure of 37.86 B MXN. In the next quarter revenue is expected to reach 39.63 B MXN.
Yes, you can track BAUSCH HEALTH COMPANIES INC financials in yearly and quarterly reports right on TradingView.
BHC/N net income for the last quarter is −680.73 M MXN, while the quarter before that showed −6.51 B MXN of net income which accounts for 89.54% change. Track more BAUSCH HEALTH COMPANIES INC financial stats to get the full picture.
Today BAUSCH HEALTH COMPANIES INC has the market capitalization of 53.65 B, it has increased by 5.29% over the last week.
No, BHC/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BHC/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAUSCH HEALTH COMPANIES INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 20.27 K employees. See our rating of the largest employees — is BAUSCH HEALTH COMPANIES INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BAUSCH HEALTH COMPANIES INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BAUSCH HEALTH COMPANIES INC stock shows the neutral signal. See more of BAUSCH HEALTH COMPANIES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BAUSCH HEALTH COMPANIES INC future price: according to them, BHC/N price has a max estimate of 272.92 MXN and a min estimate of 117.99 MXN. Read a more detailed BAUSCH HEALTH COMPANIES INC forecast: see what analysts think of BAUSCH HEALTH COMPANIES INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAUSCH HEALTH COMPANIES INC EBITDA is 49.65 B MXN, and current EBITDA margin is 32.71%. See more stats in BAUSCH HEALTH COMPANIES INC financial statements.